“I thought that we needed something bolder, something sexier, and something that reflected the realities of gay sex...”
Mr. Leather LA 2014 and LA County HIV Commission member Eric Paul Leue Photo: John Kiffmeyer
To read the complete article by Chris Tipton-King visit Huffington Post, here.
If you weren’t aware that Gilead recently started running Truvada for PrEP ads, I wouldn’t blame you: they’re exactly the sort of vanilla, stock-photo-and-fine-print yawners that you might expect from a pharmaceutical company. For a prevention strategy meant for men who enjoy dicks in butts au-natural, most
Critics say that recent conviction of Indigenous woman is further proof that the use of sexual assault laws in cases of HIV non-disclosure continue to criminalize marginalized people and women of colour
This article by Alex McClelland previously appeared in NOW Magazine, here.
An Indigenous woman with HIV has had her appeal on an aggravated sexual assault conviction dismissed by the Manitoba Court of Appeal. The decision handed down on June 29 comes as a blow to the growing movement of lawyers and human rights advocates pushing to change laws that they say criminalize people with HIV, in particular vulnerable women.
Activists have been calling for a moratorium on all n
Proposed Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act
Ontario's Regulatory Registry
Regulation - LGIC
Proposed Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act
Regulation Number(s): O. Reg. 201/96
Bill or Act: Ontario Drug Benefit Act
Summary of Proposal: As part of the 2017 Budget and the government's ongoing commitment to provide better and faster access to high-quality health services, Ontario is proposing to create OHIP+: Children and Youth Pharmacare Program.
Under the program, the province would, as
“Low-level viral loads between 400 and 999 copies/ml shortly after starting ART appear to place patients at a significantly higher 10-year risk of death than patients with viral loads under 20 copies/ml..." From AIDSmap, Michael Carter reports.
A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the United States report in the online edition of AIDS. People with a viral load between 400 and 999 copies/ml had a 20% mortality risk, similar to the 23% risk observed in people with a viral load between 1000 and 4 million copies/ml. In contrast, the mortality risk was only 14% for individuals who rapidly achieved complete viral suppressio
Activists adapt Kevin Maloney's "No Shame About Being HIV+" campaign to raise HIV awareness in Zambia. From The Zambian Analyst, Paul Shalala reports
Some of the activists who are part of the campaign -Photos by Rise Up To HIV
Over a dozen Zambian youths living with HIV and those who are passionate about fighting the spread of the virus have taken to social media to launch a campaign dubbed ‘Team No Shame About HIV+.’
The youths aim to raise awareness about their HIV status and inspire others to come out in the open and live positive lives.
In a country where being HIV positive is sometimes associated with bad behaviour, these ac
Advocates and doctors are scrambling to understand exactly when the generic will become available and how much it will cost. From TheBody.com, Sony Salzman reports.
To read the complete article by Sony Salzman, vsit TheBody.com, here.
The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become available and how much it will cost.
After weeks of speculation, both of those questions remain unanswered -- locked behind a confidential settlement agreement between TEVA,
Around 1 in 3 Brits would be ‘uncomfortable’ giving First Aid to someone with HIV on effective treatment, according to Terrence Higgins Trust survey, while nearly 40% would be ‘uncomfortable’ going on a date.
Medical evidence has shown that people living with HIV and who are on effective treatment cannot pass on the virus.
However, a major new survey by Terrence Higgins Trust has shown that only 9% of the British public are aware of this fact, which has been evidenced by scientific research.
Meanwhile around one in three (32%) adults would feel uncomfortable giving first aid to someone living with HIV who is on effective treatment, according to the YouGov survey of 2,022 adults.
And nearly 40% o
"Failure to recognise these important elements of patients’ lived experiences risks diagnostic delay, failure to address important needs, unnecessary investigations and further anxiety.” From AIDSmap. Michael Carter reports on the CIPHER Study.
One in five people living with HIV in a European study reported a decline in everyday functioning as a result of cognitive problems such as memory loss, difficulties in solving problems, poor concentration or reduced attention span, researchers from the CIPHER study group report in the Journal of Acquired Immune Deficiency Syndromes.
But, researchers say, people who reported these problems were also more likely to have comorbid conditions, to be depressed or anxious, to be unemployed and e
As of March 1, the Social Security Administration (SSA) began requiring that people living with HIV prove they are still disabled. From TheBody.com, Enid Vázquez reports.
People living with HIV (PLWH) who receive government disability checks have previously received that income without going through reviews. As of March 1, the Social Security Administration (SSA) began requiring that PLWH prove they are still disabled. Like others receiving disability payments, they will have to go through a Continuing Disability Review (CDR). These are conducted every one to seven years.
There are exceptions. Not subjected to a CDR are those with HIV who have
Richard Wolitski, Ph.D., Director, Office of HIV/AIDS and Infectious Disease Policy, US Department of Health and Human Services invites you to attend. Scroll down for the registration link.
On Friday, June 30, 2017 from 1:00 – 3:00 pm ET, the Office of HIV/AIDS and Infectious Disease Policy will host a community led “Community Response to the Effects of HIV Treatment and Viral Suppression on Transmission” webinar.
To register CLICK HERE
In the last year, compelling new evidence has demonstrated that HIV treatment significantly reduces sexual transmission of HIV. In addition, this research found no cases of HIV that were transmitted sexually by individuals with a suppress
Leading HIV and sexual health charity Terrence Higgins Trust has launched a brand new, Scotland-wide peer support service, to enable people to live well with HIV.
Although advances in medication mean that people with HIV can now live long and healthy lives medically, they still face stigma and discrimination, which can lead to isolation and low self-esteem. Nearly 60 per cent of people with HIV in Scotland have experienced low self-esteem, and a quarter have felt suicidal. 
Now, Peer Support Scotland, funded by the Big Lottery Fund Scotland, will bring together people living with HIV to share their experiences, knowledge and advice, to support other
Guest author Michael Liddell: "... people who use drugs and their allies are using the mantra of 'nothing about us without us' to organize and demand action."
At the opening of the 25th Harm Reduction International Conference in Montreal held in Montreal in May of this year, the Federal Minister of Health Jane Philpott announced that more people have died in the overdose epidemic in the past few years than during the height of the AIDS crisis in the late 80s and early 90s. This fact is made even more tragic considering that it need not happen.
This grim reality was on the minds of many and was the catalyst for a workshop hosted by Direction 180
Horwath: “Whether it’s PrEP or HIV treatment, we believe that no one should have to empty their wallet to get the medicine they need,”
QUEEN’S PARK – Today (June 20, 2017) , Ontario NDP leader Andrea Horwath hosted a roundtable discussion with people living with HIV and leaders in the fight to improve access to HIV treatment and prevention in Ontario.
A key topic during the discussion was the cost of life-saving drugs to treat and prevent HIV, and the NDP Pharmacare plan.
“Whether it’s PrEP or HIV treatment, we believe that no one should have to empty their wallet to get the medicine they need,” said Horwath.
Six members of the Presidential Advisory Council on HIV/AIDS (PACHA) have resigned. From Newsweek, Scott A. Schoettes has this report.
To read the complete article by Scott A. Schoettes, visit Newsweek, here.
Five of my colleagues and I resigned this week from the Presidential Advisory Council on HIV/AIDS (PACHA). As advocates for people living with HIV, we have dedicated our lives to combating this disease and no longer feel we can do so effectively within the confines of an advisory body to a president who simply does not care.
The Trump Administration has no strategy to address the on-going HIV/AIDS epidemic, seeks z
HALCO's Ryan Peck:"The fact is that rights, especially for marginalized communities, are constantly under attack."
Note: This speech was presented by Ryan Peck, Executive Director of the HIV & AIDS Legal Clinic Ontario (HALCO) upon accepting the Legal Aid Ontario 2016 Sidney B. Linden Award.
Before focusing on what we at HALCO humbly refer to as holistic and revolutionary (or at least incremental reformist) lawyering, as well as on legal injustices facing people with HIV, I pay tribute to the countless who are no longer with us.
HALCO was founded in a dark time. Death was an everyday experience and p